Insulin resistance in hypertensive patients depending on cardiovascular risk
https://doi.org/10.18705/1607-419X-2015-21-4-378-385
Abstract
Objective. To examine the rate of insulin resistance (IR) in groups of different cardiovascular risk in hypertensive patients and to evaluate the effect of IR on risk factors and vascular lesion.
Design and methods. The study included 150 patients (82 men and 68 women). Patients were divided into five groups: groups 1–4 included patients with hypertension (HTN) and different level of cardiovascular risk (the SCORE model), 5th group was the control group. Each of the groups was divided into 2 subgroups: patients with and without IR.
Results. IR was verified in all groups of cardiovascular risk, but it was predominant in very high-risk patients. IR correlated with body mass index and hypertriglyceridemia. IR rates were equal in middle- and high-risk patients. IR was associated with myocardial remodeling in high-risk group.
Conclusions. HOMA-IR index is an important biological marker of the presence of cardiovascular risk factors in hypertensive patients. We believe that an estimate of IR may help to personalize health care and improve the prognosis of hypertensive patients, even in patients without clinical manifestations of IR and impaired glucose metabolism. Further research is needed to study the role of identifying IR in the definition of medical approaches in HTN
About the Authors
N. N. Kryukov
Samara State Medical University
Russian Federation
Russian Federation
MD, PhD, Professor, Chief, Department of Internal Diseases,
Samara
Y. F. Titova
Samara State Medical University;
The Railway Clinical Hospital on Station Samara
Russian Federation
Russian Federation
MD, PhD Student,
Endocrinologist,
13 Aksakov street, Samara, 443030
G. I. Kiseleva
Samara State Medical University
Russian Federation
Russian Federation
MD, PhD, Assistant Professor, Department of Internal Diseases,
Samara
I. V. Gubareva
Samara State Medical University
Russian Federation
Russian Federation
MD, PhD, Assistant Professor, Department of Internal Disease,
Samara
References
1. Lewington S, Clarke R, Qizibash N, Peto R, Collins R. Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913.
2. Pyirala K, de Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J.1994;15(10):1300–1331.
3. Conroy RM, Pyirala K, Fitzgelald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24 (11):987–1003.
4. ESH/ESC Guidelines for the management of arterial. Eur Heart J. 2013;34(28):2159–2219.
5. Диагностика и лечение артериальной гипертензии. Российские рекомендации ВНОК (четвертый пересмотр). Системные гипертензии. 2010;3:34. [Diagnosis and treatment of arterial hypertension. Russian Society of Cardiology Guidelines. Sistemnye gipertenzii = Systemic Hypertension. 2010;3:34. In Russian].
6. de Boer MP, Meijer RI, Wijnstok NJ, Jonk AM, HoubenAJ, Stehouwer CD et al. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation. 2012;19(1):5–18.
7. Кобалава Ж.Д., Котовская Ю.В., Моисеева В.С. Артериальная гипертония. Ключи к диагностике и лечению.М.: ГЭОТАР-Медиа; 2009. 864 c. [Kobalava ZhD, Kotovskaja YV, Moiseeva VS. Hypertension. Keys to diagnostics and treatment. Moscow: GEOTAR-Media; 2009. 864 p. In Russian].
8. Ferrannini E, Natali A, Capaldo B. Insulin resistance, hyperinsulinemia and blood pressure: role of age and obesity. European group for the study of Insulin Resistance (EGIR). Hypertension.1997;30(5):1144–1149.
9. Скудаева Е.С., Пашенцева А.В., Вербовой А.Ф. Уровни резистина, адипонектина и инсулинорезистентности у пациентов с разной степенью нарушений углеводного обмена. Ожирение и метаболизм. 2011;3:57–60. [Verbovoy AF, Pashenceva AV, Skudaeva ES. Levels of resistin, adiponectin and insulin resistance in patients with different degree of carbohydrate metabolism disorder. Ozhirenie i Metabolism = Obesity and metabolism. 2011;3:57–60. In Russian].
10. Дедов И. И., Шестакова М.В. (ред.). Сахарный диабет: острые и хронические осложнения. Под ред. И.И. Дедова, М. В. Шестаковой. М.: ООО Издательство «Медицинское информационное агентство»; 2012. 480 c. [Dedov II, Shestakova MV (eds.). Diabetes mellitus: acute and chronic complication Ed. II Dedov, MV Shestakova. Moscow: Publisher «Medical information Agency»; 2012. 480 p. In Russian].
11. Перова Н. В., Озерова И. Н., Александрович О. В., Метельская В.А., Шальнова С.А. Клиническое значение инсулинорезистентности при нормогликеми натощак. Кардиология. 2011;8:49–53. [Perova NV, Ozerova IN, Alexandrovitch OV, Metelskaya VA, Shalnova SA. Clinical value of insulin resistance in fasting normoglycemia. Kardiologiia. 2011;8:49–53. In Russian].
12. Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imag. 2012;13(1):1–46.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocard. 2006;7(2):79–108.
14. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26(12):3320–3325.
15. Rutter RM, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular eventsin the Framingham Offspring Study. Diabetes. 2005;54(11):3252–3257.
Review
For citations:
Kryukov N.N., Titova Y.F., Kiseleva G.I., Gubareva I.V. Insulin resistance in hypertensive patients depending on cardiovascular risk. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2015;21(4):378-385. (In Russ.) https://doi.org/10.18705/1607-419X-2015-21-4-378-385
Views:
1381
Email this article 